CON-TGO91-339 - Sanofi-Aventis Australia Pty Ltd
Product names
- AUST R 10113 - RIFADIN rifampicin 20 mg/mL oral liquid bottle
- AUST R 156919 - RIFADIN rifampicin 600 mg powder for injection vial with diluent ampoule
- AUST R 233442 - RIFADIN rifampicin 150 mg capsules blister pack
- AUST R 233443 - RIFADIN rifampicin 300 mg capsules blister pack
Sponsor
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 31 May 2021.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines